Fundraising Fox
Find your path to Genghis
Sign up to see every warm intro you have to Genghis
- Paths you didn't know you had: your email and LinkedIn already hold routes to Genghis. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Genghis Lloyd-Harris is a Senior Advisor to Abingworth and formerly a Partner, where his work centered on exiting venture investments through M&A and IPOs. He joined Abingworth in 2004 from Credit Suisse First Boston, where he was a Managing Director in the European Equity Research Group in London covering the biotechnology industry, having earlier worked in CSFB's Health Care investment banking group in New York. He previously practiced as a paediatrician in Melbourne and holds a Medical Degree from the University of Liverpool, a PhD in Clinical Pharmacology from the University of Melbourne, and an MBA from Harvard Business School.
Invests in
Biotech
Deals · 1
Gensight Biologics S.ABoard seat
via Abingworth · filed Jul 2015 · $25M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AvillionGenSight BiologicsHealthcare Brands InternationalNouscomNovexelSolexaSynosiaSyntaxinWilson Therapeutics
Investor
NouscomSynosia TherapeuticsSyntaxinWilson Therapeutics
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Abingworth
Network5
Investors connected to Genghis in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Genghis Lloyd-Harris?
- Genghis Lloyd-Harris is a Senior Advisor to Abingworth and formerly a Partner, where his work centered on exiting venture investments through M&A and IPOs. He joined Abingworth in 2004 from Credit Suisse First Boston, where he was a Managing Director in the European Equity Research Group in London covering the biotechnology industry, having earlier worked in CSFB's Health Care investment banking group in New York. He previously practiced as a paediatrician in Melbourne and holds a Medical Degree from the University of Liverpool, a PhD in Clinical Pharmacology from the University of Melbourne, and an MBA from Harvard Business School.
- Where does Genghis Lloyd-Harris work?
- Genghis Lloyd-Harris is Partner at Abingworth.
- What does Genghis Lloyd-Harris invest in?
- Genghis Lloyd-Harris invests in Biotech.
- What check size does Genghis Lloyd-Harris write?
- Genghis Lloyd-Harris typically writes checks of $15M – $30M.
- What boards does Genghis Lloyd-Harris sit on?
- Genghis Lloyd-Harris holds tracked board seats at Avillion, GenSight Biologics, Gensight Biologics S.A, Healthcare Brands International, Nouscom, Novexel, Solexa, Synosia, Syntaxin, Wilson Therapeutics.
- What companies has Genghis Lloyd-Harris invested in?
- Investments tracked here include Gensight Biologics S.A, Nouscom, Synosia Therapeutics, Syntaxin, Wilson Therapeutics.
About this profile. Compiled from public sources — Abingworth's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights